4534
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

Mochida Pharmaceutical Co., Ltd. is a pharmaceutical and healthcare company engaged in the manufacturing, procurement, and sales of medicines and health products. The company operates through two main business segments: pharmaceuticals and healthcare. In the pharmaceutical segment, it outsources manufacturing to subsidiaries Mochida Pharmaceutical Factory Co., Ltd. and Technofine Co., Ltd., while handling sales through Mochida Pharmaceutical Sales Co., Ltd. and Mochida Medical USA, Inc. The healthcare segment is managed by Mochida Healthcare Co., Ltd., which also utilizes Mochida Pharmaceutical Factory Co., Ltd. for production. The group includes six consolidated subsidiaries and one affiliate, with And Pharma Co., Ltd. participating in the distribution of certain pharmaceutical products.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Drug Manufacturers - General Homepage mochida.co.jp
Sector Healthcare IR page mochida.co.jp
Tags
pharmaceuticals, healthcare products, medical devices, manufacturing, sales, outsourced production, Mochida Pharmaceutical Factory Co. Ltd., Mochida Pharmaceutical Sales Co. Ltd., Mochida Medical USA Inc., Technofine Co. Ltd., Mochida Heartful Service Co. Ltd., Mochida Healthcare Co. Ltd., And Pharma Co. Ltd.
Press page mochida.co.jp/ir/news/index.html

Metrics

Valuation  
Market cap ¥ 115.902B
Market cap (USD) $ 724.397M
P/E 10.47
PEG 1.77
P/BV 0.81
P/S 0.92
P/OCF -9.46
P/FCF -8.03
Dividend yield 2.5%
Turnover / mcap —
Returns  
ROE 5.8%
ROI 5.3%
ROIC 4.8%
Profit margin 6.8%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) 5.9%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock Yes
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 16.7%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 116.951B 105.159B 102.885B 103.261B 110.179B 102.995B 101.799B 109.643B 106.761B 97.349B 92.272B 87.252B 93.947B 89.21B
Net profit 7.903B 5.685B 4.547B 6.649B 10.569B 8.587B 4.598B 8.435B 9.023B 8.526B 8.15B 7.544B 9.892B 9.152B
Free cash flow -10.045B 7.194B -9.776B 5.131B 4.471B 7.263B 7.389B 11.197B 2.188B 4.477B 13.384B — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Share price 3.457K 3.175K 3.219K 3.341K 3.736K 4.285K 4.17K 5.687K 7.493K 8.253K 4.184K 3.946K 7.379K 6.06K
Price performance 12m 0.09 -0.01 -0.04 -0.11 -0.13 0.03 -0.27 -0.24 -0.09 0.97 0.06 -0.47 0.22 —

Filed figures

Figure Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (JPY) 30.8B 31.8B 29.3B 28.4B 29.2B 31.7B 27.8B 34.8B 31.6B 72.6B
↳ YoY growth +17.5% +3.2% -7.6% -3.0% +2.6% +8.5% -12.2% +25.3% -9.2% +129.8%
↳ 5y CAGR +2.2% +0.6% -2.6% +3.5% +2.1% +20.0%
Borrowings, non-current (JPY) — — — — — — — — — 10B
Cash and deposits (JPY) 46.3B 45.7B 51B 53.3B 54.5B 48.4B 47B 33.3B 45.2B 28.1B
Intangible assets (JPY) 410M 365M 372M 674M 646M 713M 797M 721M 920M 1.12B
Net debt (borrowings + leases - cash) (JPY) — — — — — — — — — -18.1B
Cash flow detail
Operating cash flow (JPY) 5.58B 3.28B 12.6B 9.35B 9.2B 7.46B 7.3B -7.48B 9.35B -7.35B
Purchases of property, plant and equipment (JPY) -1.11B -1.1B -1.37B -1.96B -1.94B -2.99B -2.17B -2.3B -2.16B -2.7B
Change in receivables (cash effect) (JPY) -4.59B -976M 2.43B 890M -740M -2.49B 3.87B -7.03B 3.22B -4.86B
Change in inventories (cash effect) (JPY) -3.44B -3.74B 362M -428M 2.47B -521M -1.28B -5.87B -3.02B -2.83B
Change in payables (cash effect) (JPY) 5.8B -559M -3.03B 192M -3.93B 2.18B -1.94B 2.23B -3.52B 2.12B
Dividends paid (cash effect) (JPY) -2.73B -3.42B -3.53B -3.34B -3.1B -3.45B -3.37B -2.89B -2.84B -2.84B
Share buybacks (cash effect) (JPY) -16M -15M -2.52B -1.99B -2.01B -2.51B -3.51B -3.49B -3M -2M
Income taxes paid (cash effect) (JPY) -5.21B -3.86B -3.48B -1.95B -2.15B -3.62B -3.22B -1.37B -948M -2.35B
Operating cash flow before change in receivables (JPY) 10.2B 4.26B 10.1B 8.46B 9.94B 9.95B 3.43B -448M 6.13B -2.49B
Free cash flow (OCF - PPE - intangibles) (JPY) 4.48B 2.19B 11.2B 7.39B 7.26B 4.47B 5.13B -9.78B 7.19B -10B
Income detail
Research and development expense (JPY) 15.2B 11.9B 13B 11.9B 10.8B 12.3B 13.3B 12.6B 11.7B 12.2B
↳ 5y CAGR -4.2% -4.2% +2.2% -0.7% -0.4% +2.3%
Total comprehensive income (JPY) 9.69B 11.3B 11.5B 873M 11.4B 7.62B 5B 7.57B 5.57B 12.4B
Comprehensive income to owners (JPY) 9.69B 11.3B 11.5B 873M 11.4B 7.62B 5B 7.57B 5.57B 12.4B
Reported Jun 29, 2017 Jun 28, 2018 Jun 27, 2019 Jun 26, 2020 Jun 29, 2021 Jun 29, 2022 Jun 29, 2023 Jun 27, 2024 Jun 27, 2025 Jun 24, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Mochida Pharmaceutical Co., Ltd. (ticker 4534), listed in Japan.

ETFs Holding Mochida Pharmaceutical Co., Ltd.

ETF Weight in ETF Shares Market value As of
AVDS 0.02% 3,000 $ 63.064K Nov 16, 2026
DISV 0.02% 46,900 $ 982.583K Nov 12, 2026
DFIS 0.01% 40,000 $ 838.024K Nov 12, 2026
DXIV 0.01% 1,400 $ 29.331K Nov 12, 2026
DFIC 0.00% 23,478 $ 491.878K Nov 12, 2026
DFAX 0.00% 14,500 $ 303.784K Nov 12, 2026
DFSI 0.00% 1,400 $ 29.331K Nov 12, 2026
DFAI 0.00% 11,500 $ 240.932K Nov 12, 2026
AVDE 0.00% 13,000 $ 273.277K Nov 16, 2026